Focus: Reprogramming symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit
Tenza is a life sciences company focused on Reprogramming symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit.
Profile data last refreshed Yesterday
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Help build intelligence for Tenza
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.